patent/CN-103570709-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103570709-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02f24694b4445e31254823f04656311e
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate	2012-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afb5794a4583e078d3a2b8d68ce72151 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6e62fe2cc7d1425b5dd5ffe13878a22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aa493e306d5704903ddaf67b2194284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c17f229440dd750619ba39d77262164d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b0083767ce4c114200476e51d542d50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf2bcc8eb1c0984904d079870f5c6548 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b286bdfb14875127238a2c6dafefa0d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26f2743748199dcb801e61c414d2a18a
publicationDate	2014-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-103570709-A
titleOfInvention	A class of pyrazolopyridine compounds and their preparation method, use and pharmaceutical composition
abstract	The present invention provides pyrazolopyridine compound of general formula (I), its preparation method, application and pharmaceutical composition. Such compounds can inhibit PI3K activity, and therefore can be used for the preparation of medicines for treating diseases or diseases caused by dysfunctional PI3K-AKT-mTOR signaling pathways, such as malignant tumors, immune diseases, cardiovascular diseases, Inflammation, metabolic/endocrine dysfunction and neurological diseases, etc. General formula (I)
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10899755-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103626783-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10934288-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11242343-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103626783-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10800761-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11492354-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10752635-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11731958-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11542265-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116239594-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116239594-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9573953-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10745388-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11066394-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10722495-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11014929-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11299473-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406624-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11111247-B2
priorityDate	2012-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009055418-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1980561-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466995241 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466823032 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468184975

Total number of triples: 54.